BridgeBio Pharma logo

Director, Analytical Development

BridgeBio Pharma

Any City, USRemotePosted 1 day ago$144,000 - $159,000/year
Full TimeDirector & AboveManufacturing & CMCBiotechnology
Original posting ↗

Summary

Responsible for managing the development and tracking of stage-appropriate testing methodology for drug substance and drug product, including in-process, release, stability, method validation and site transfer under aggressive timelines.

Job description

What You'll Do

Responsible for managing the development and tracking of stage-appropriate testing methodology for drug substance and drug product, including in-process, release, stability, method validation and site transfer under aggressive timelines.

Communicate and coordinate with internal Analytical, CMC, QA, Regulatory, Project Management and consultants, as well as with external CROs/CMOs counterparts.

Manage critical analytical review of SOPs, test methods and specifications for raw materials/intermediates/drug substance/drug product, development/verification reports, validation protocols/reports, method transfers, COAs and stability summaries.

Support contractor site investigations pertaining to OOS/OOT and deviations.

Responsibilities

  • Support Analytical (CMC) activities associated with the formulation of infigratinib.
  • Work closely with your Analytical Development colleagues and external CROs/CMOs collaborators to rapidly advance programs to key decision points, in preparation of regulatory submission, approval and post-approval commitments.
  • Assist in data generation and analysis.
  • Ensure analytical development activities are aligned with the project's overall objectives.
  • Assist in regulatory filings.
  • Perform data review & stability tracking.

Where You'll Work

Remote with 30% travel anticipated.

Who You Are

  • MS in Organic Chemistry, Analytical Chemistry, Pharmaceutical Science.
  • 5+ years' experience in the contract research or pharmaceutical/biotech industry.
  • Demonstrated abilities in the development and application of analytical assay, impurity, and in-vitro (dissolution) release.
  • Experience in high performance liquid chromatography and physicochemical properties (solubility, solid state, physical testing), methods development, drug substance and drug product.
  • Knowledge of cGMP regulations, including compendial (USP, EP, JP) and guidance documents.
  • Working knowledge of FDA, EMA and ICH guidelines.

Requirements

  • MS in Organic Chemistry, Analytical Chemistry, or Pharmaceutical Science
  • 5+ years' experience in the contract research or pharmaceutical/biotech industry
  • Demonstrated abilities in the development and application of analytical assay, impurity, and in-vitro (dissolution) release
  • Experience in high performance liquid chromatography and physicochemical properties (solubility, solid state, physical testing), methods development, drug substance and drug product
  • Knowledge of cGMP regulations, including compendial (USP, EP, JP) and guidance documents
  • Working knowledge of FDA, EMA and ICH guidelines

Benefits

  • 401(k) Matching
  • Employee Stock Purchase Program
  • Pre-tax Commuter Benefits
  • Referral Bonus
  • Subsidized Lunch & Parking
  • Medical, Dental & Vision
  • Health Savings Account
  • Flexible Spending Accounts
  • Fertility & Family-Forming Benefits
  • Mental Health Support
  • Flexible PTO
  • Paid Medical & Parental Leave

Company overview

BridgeBio Pharma is a pioneering biopharmaceutical company founded in 2015 with a mission to discover, create, test, and deliver transformative medicines for patients suffering from genetic diseases. Headquartered in Palo Alto, California, the company operates as a new type of biopharmaceutical organization that bridges the gap between remarkable advancements in genetic science and patients with unmet medical needs. BridgeBio focuses on Mendelian diseases, which arise from defects in a single gene, and cancers with clear genetic drivers. The company's innovative approach involves identifying and advancing promising scientific discoveries through a portfolio model that spans early discovery to late-stage development. With a pipeline of over 20 development programs, BridgeBio employs a team of experienced drug discoverers, developers, and innovators committed to applying advances in genetic medicine to help patients as quickly as possible. The company's business model combines scientific expertise with entrepreneurial execution to address rare genetic conditions that have historically been overlooked by traditional pharmaceutical companies due to small patient populations and industry reluctance to conduct early-stage development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.